Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
FUBP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
BIRC5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TNFRSF25 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VDR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
ZFR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BAP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PHB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
USP8 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FOXJ3 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GHRLOS - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
ORC2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARSB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SEC11A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APEX1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ADPGK - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TIMM13 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on